Abstract. Objective: To establish the usefulness of specific ultrasound (US) features as indications for ultrasoundguided fine needle aspiration biopsy (FNAB) in incidentally found infracentimetric thyroid nodules. Methods: The ultrasonographic features and cytology of FNAB samples of 96 histopathologically-proven papillary microcarcinomas (less than 1 cm in long diameter) and 75 less than 1 cm sized benign nodules were analyzed and compared. The risk of malignancy indicated by each US feature was calculated by logistic regression analysis. Results: Among the US features examined, internal content, shape, margin, echogenicity, and calcifications showed statistically significant differences between benign and malignant infracentimetric nodules. Crude odds ratios (OR) and 95% confidence intervals (CI) for risk of malignancy were, for solid content, OR = 39.3 (95% CI = 3.3-4.64); for taller than wide shape, OR = 14.2 (95% CI = 1.43-14.1); for hypoechogenicity, OR = 3.57 (95% CI = 1.31-9.86); for marked hypoechogenicity, OR = 31.33 (95% CI = 6.63-14.8); and for coarse macrocalcifications, OR = 3.43 (95% CI = 1.04-11.3). Conclusions: Infracentimetric nodules that are solid, taller than wide, hypoechogenic or markedly hypoechogenic, and have coarse microcalcifications and macrocalcifications have a high risk of malignancy, indicating further assessment.
THYROID nodules which measure less than one centimeter in largest diameter [1] , have many controversial issues on diagnosis, prognosis and treatments. Many investigators have not considered microcarcinomas clinically significantly due to an extremely indolent tumor with favorable prognosis [2, 3] . Others reported up to 5% of papillary microcarcinoma with invasion of capsule or distant metastasis [4] and Lee et al. [5] reported 28.0% of extrathyroidal extension and 29.7% of lymph node metastasis suggesting micropapillary carcinomas also need aggressive investigations. Also no agreement or consensus for biopsing less than one centimeter nodule has been made yet. According to The American Thyroid Association guidelines [6] , US-FNA is recommended for nodules > or =10 mm; and for nodules <10 mm only if clinical information or US features are suspicious. Society of Radiologists in Ultrasound [7] advocates biopsy for lesions greater than 1.5 cm. Performing US-FNAB on all nodules that measure less than 1 cm in long diameter would lead to an excessive number of biopsies and reduced costeffectiveness. Thus, improved knowledge of US features indicating benign and malignant infracentimetric thyroid nodules is needed. The present study examined US features of histopathologically-proven papillary microcarcinomas, as well as the accuracy of US-FNAB, to establish criteria for evaluating infracentimetric thyroid lesions.
Materials and Methods

Subjects and histopathology
During 2003-2006, 2614 consecutive patients were referred to radiology department in Seoul National Bundang hospital, South Korea for US guided FNA. The selection of patients for FNAB was based on the American Thyroid Association guidelines [6] . FNAB candidates measuring less than 1 cm were having at least one suspicious malignant finding on ultrasound exam [8] . A flowchart Diagram of FNAB patients and patients selected for surgical procedure are shown on Fig. 1 ) . The other larger than 1 cm nodules in 163 patients were confirmed as 61 benign and 102 malignant. We received informed consents for all the patients who were included in our study. Surgically removed thyroid specimens were subjected for histopathological examinations. For histologically proven 96 micropapillary carcinomas were compared to 79 benign confirmed nodules and 102 larger than 1 cm papillary carcinomas were analyzed of subjective ultrasonographic findings.
Surgical procedures
The type of surgical procedure was mainly up to the thyroid surgeon but generally in our institution when the nodule measures less than 1 cm and confined within the thyroid parenchyma without a definite evidence of lymph node metastatsis, hemithyroidectomy was enough. When microcarcinoma was located on isthmus or adjacent to peri-thyroidal capsule, or definite invasion of surrounding strap muscle was evident with or without lymph node metastasis, total thyroidectomy was performed.
US feature evaluation, FNAB technique, and cytology
Ultrasound was performed using a Philips IU22 and an HDI 5000 (Advanced Technology Laboratories Bothell, WA), each with a 7-12 MHz probe. When determining the benign, borderline, malignant in each nodule using the US finding only we defined malignancy if the nodule had at least one of the following features associated with malignancy, (solid, taller than wide, spiculated margin, marked hypoechogenicity, microcalcifications, macrocalcificatons) it was considered as malignant nodule [8] . Sponge-form nodule, isoechogenic nodule, and predominantly cystic nodule or entirely cystic nodules were considered as probably benign nodule. When nodule showed neither malignant or benign US finding and with at least one of the following findings such as isoechoic, hypoechoic or hyperechoic nodule with round or irregular shape with ill defined margin with or without peripheral rim calcifications were defined as borderline nodule.
For surgically confirmed 175 infracentimetric nodules and 102 larger than 1 cm papillary cancer retrospective analysis of US features-tumor location, size, internal content, orientation, shape, margin, echotexture, echogenicity, and calcifications-were done by two radiologists with consensus was reached. When we reviewed the images saved on PACS, we were blinded to the pathology.
Above mentioned US features between surgically confirmed papillary microcarcinoma (n = 96) and 79 benign nodules (n = 71 adenomatous hyperplasia and follicular adenoma, n = 8 hurthle cell adenoma), frequencies of US features were compared and Odds ratios (OR) for risk of malignancy were calculated. For larger papillary carcinomas (n = 102) subjected US features were analyzed and compared it to micropapillary carcinomas (n = 96). Internal content was described as predominantly solid if the solid portion consists more than 50% and if the solid portion comprises less than 50% it was defined as predominantly cystic. We defined solid when the nodule had internal echogenicity throughout the lesion. Shape was divided as oval to round, taller than wide, and irregular. We defined taller than wide when the height was taller than the width of a nodule on transverse scan. When the nodule was not be able to describe as oval shape or round shape, and can not duplicate the nodule in drawing, we defined it as irregular. We defined margin as well defined when either complete low echoic rim was present or when the full margin of the nodule was able to follow through. For the echogenicity, we defined markedly hypoechoic when the nodule showed echogenicity near to anechoic but internal solid content was visualized and echogenicity that is much lower than the adjacent strap muscle. Microcalcifications were defined as small calcifications measuring less than 1 mm, visualized as focal dot and macrocalcifications were defined as calcifications that are larger than 2 mm.
US-FNAB was performed by board certified radiologists, using a 23 gauge needle attached to a 10 cc syringe with an aspirator with movement of the needle tip toward and into the target was visualized in real time-US. Based on cytological evaluation, the nodules were classified as malignant, suspicious, benign, or inadequate sample. Cytological results were compared to histopathological results for each nodule.
Statistical analyses
Frequencies of US features were compared for benign and malignant tumors using Chi-square tests. Probability levels less than 0.05 were considered statistically significant. Odds ratios (OR) for risk of malignancy were calculated for each US feature by logistic regression analysis, using SPSS version 10.0 (SPSS, Chicago, USA).
Results
Histopathological results
Among the 175 removed nodules 96 were confirmed as papillary microcarcinomas and the remaining 71 were adenomatous hyperplasia and 8 cases were hurthle cell adenomas. Most benign confirmed nodules were nodules that were consequently removed when the contralateral large (more than 4 cm) nodule was removed for the cosmetic purposes, or when the cytology results were inadequate at first FNAB and indeterminate on repeated FNAB or indeterminate cases (8%) or when the patient strongly wanted to have it removed. Among 163 removed larger nodules. 102 were papillary carcinoma and 61 cases were benign pathology mostly adenomatous hyperplasias.
Ultrasonographic results
Of the 343 thyroid nodules evaluated, 175 were infracentimetric. US features of infracentrimetric nodules with FNAB cytology results with corresponding surgical pathology results are shown on Table 1 . In five cases (2.4%) of nodules that measured less than 0.2 cm, US results proved to be false negatives, in such cases, US features were considered as benign finding but the final surgical pathology was papillary microcarcinomas which were calculated as false negative cases. Comparison of US and histopathological results for the same infracentimetric nodules indicated that the sensitivity, specificity, and accuracy, of US examination were 73.9, 69.6, and 71.8% respectively. There were no significant differences in the mean size or location of the 79 benign and 96 malignant nodules (Table 2) . Internal content, shape, margin, echogenicity, and calcifications all showed statistically significant differences between benign and malignant infracentimetric nodules. Solid content, taller than wide shape, hypoechogenicity or marked hypoechogenicity, ill-defined margin, and micro-or macrocalcifications were all statistically 
Benign pathology consisted of 71 Adenomatous hyperplasias and 8 cases of Hurtle cell adenomas. Malignant pathologies were all consists of papillary thyroid carcinomas. Fine needle aspiration results represent final results when repeated FNABs were performed. Odds ratios and confidence intervals were calculated only for features showing significant differences between benign and malignant nodules. US features in between infracentimetric nodule and larger nodule differences were statistically significant with chi-square test with p-value less than 0.05.
more frequent in malignant than in benign nodules. When 102 papillary carcinomas larger than 1 cm were compared to micropapillary carcinomas differences in internal content (p = 0.001), shape (p = 0.000), margin (0.002) echogenicity (p = 0.000) and calcifications (p = 0.000) all showed statistically significant difference ( Table 2 , p-value not shown on the table).
US-FNAB cytology
Results of US-FNAB cytology of the 175 infracentimetric nodules indicated that 88 (50.3%) were benign, 73 (41.7%) were positive for malignant cells, 14 (8%) were indeterminate, at the final cytology results when repeated FNAB were performed. When compared to histopathological results, the sensitivity, specificity, and accuracy of US-FNAB were 90.6, 80.1, and 92%, respectively. US-FNAB cytology successfully indicated malignancies on the first biopsy in 64 patients, and on a second, repeated biopsy in 24 patients. When calculating the accuracy, indeterminate cases were considered as true positive and for sensitivity. Initial FNAB cytology results for infracentimetric nodules and larger than 1 cm nodules are summarized in Table  3 . Larger nodules showed lower rate of inadequate specimen (12.6% versus 2.9%) in initially performed FNAB cytology result. When compared cytology results of larger nodules to infracentimetric nodules, the differences were statistically significant with pvalue of 0.000.
Discussion
Investigating subcentimeter thyroid nodules has been discussed by many groups of medical specialists, and most have concluded that these nodules do not need invasive procedures until they cause clinical problems [2, 4] . But recently published reports demonstrate the size of papillary thyroid cancer is an important prognostic factor [9] , and it can be associated with local or even distant metastasis [2, 5, 10] . Performing US-FNAB only on nodules greater than 1 cm is because it is believed that smaller nodules show an indolent course [4, 11] , but in clinical practice, we have experienced lymph node metastasis which increased the stage and local recurrences. Despite the fact that infracentimetric nodule management has not reached consensus, patients' interests is weather the nodule has any risk of malignancy. Knowledge of US features that differ between benign and malignant nodules is important in determining the advisability of US-FNAB. Kim et al. [8] suggested the need to identify relatively sensitive and highly specific US features of high risk nodules worthy of FNAB but did not consider the size. While many previous studies examined US features of thyroid tumors [3, 10, 12, 13] , few studies examined features of microcarcinomas, or compared features of micropapillomas and benign nodules. Results of the present study provide that information, by identifying specific US features as significant indicators of malignancy.
Ito et al. in their published paper on US evaluation of thyroid nodules on 900 patients suggested that the accuracy of US diagnosis as malignancy depends on the size of the nodules and small papillary carcinoma is less likely to have a malignant ultrasound classifications [14] but our study results of US diagnosis in micropapillary carcinoma showed about 70% sensitivity, specificity and accuracy. Combined with FNAB results reaching up to 90% diagnostic accuracy, we believe that infracentimetric nodules also can be very well evaluated by US and US guided FNAB. But when compared to larger papillary carcinomas, larger nodules had more obvious US features of malignancy and less inadequate specimen as an initial cytology results.
When comparing the US feature of micropapillary carcinoma to benign confirmed nodule, the finding of micropapillary carcinoma in internal content, only one of 96 nodules confirmed as malignant was classed as predominantly cystic (Table 2 ), a very low proportion compared to a previous study which reported that 17.6% of malignant nodules were cystic or predominantly cystic [15] . Cystic degeneration is unusual in very small nodules, so infracentimetric nodules with solid internal content have a high risk of being malignant. The shape and margin characteristics of a thyroid nodule also provide an indication of risk of malignancy. Kim et al. [8] suggested that taller than wide nodules are suggestive of malignancy. In the present study, 22.9% of infracentimetric nodules that were confirmed as malignant were taller than wide (Fig. 2) , compared to only 1% of benign nodules. Thus, the risk of malignancy in taller than wide nodules was 14.2 times that of oval to round nodules (Table 2) . Irregular shape and an ill-defined margin are generally considered indications of malignancy. Our results did not support this, as a high percentage of benign Fig. 2 . High resolution sonography feature of papillary microcarcinoma (arrow) shows ill defined, taller than wide nodule, and with suspicious internal microcalcifications. Fig. 3 . This papillary microcarcinoma confirmed nodule (arrow) shows a marked hypoechogenicity with ill defined irregular taller than wide nodule. Marked hypoechogenicity is echogenicity that is lower than strap muscle, near anechoic but with definite internal solid echogenicity.
Fig. 4.
Single incidental infracentimetric nodule with coarse calcifications (arrows) that was thought to be a degenerating adnoma but pathology proved to be papillary microcarcinoma. infracentimetric nodules had ill-defined margins (41.8%) and/or an irregular shape (16.5%).
Results of the present study showed that hypoechogenicity and marked hypoechogenicity were indications of malignancy in infracentimetric nodules. Markedly hypoechogenic nodules (Fig. 3) had 31 times higher risk of malignancy that isoechogenic nodules (Table 2 ). Because none of the 96 confirmed malignant nodules showed hyperechogenicity, hyperechogenic infracentimetric nodules are probably not candidates for FNAB. Kim et al. [8] differentiated between markedly hypoechogenic nodules and other hypoechogenic nodules, and concluded that only markedly hypoechogenic nodules were indicative of malignancy. Our results showed that hypoechogenic nodules have a significantly higher risk of malignancy than isoechogenic nodules. However, a relatively high percentage of benign nodules were also hypoechogenic (Table 2) , so this feature alone cannot be considered as an indication of malignancy or a basis for FNAB.
The present study found calcifications in 55% of confirmed papillary microcarcinomas. Twenty percent were tiny punctuate microcalcifications, typically seen as psammoma bodies in papillary cancer; 23% were coarse macrocalcifications (Fig. 4) ; and 13% were peripheral rim or arc-like linear calcifications (Fig. 5) . It is generally accepted that peripheral rim calcifications are characteristic of degenerating adenomatous nodules in multinodular goiters [16] , but our finding of peripheral rim calcifications in thyroid nodules indicates that further study of this US feature is needed. Sahin et al. [17] reported that microcalcifications were the only statistically significant US feature indicating malignancy in infracentimetric nodules. Our results corroborated that microcalcifications indicate a significant risk of malignancy, but the risk was even higher for infracentimetric nodules with coarse or peripheral rim calcifications than with the tiny punctuate microcalcifications typically seen in papillary microcarcinomas. This result might be due to the difficulty of observing tiny punctuate microcalcifications in nodules less than 1 cm in diameter. Our study also found that small percentages of benign nodules exhibited punctuate microcalcifications (5%) or coarse macrocalcifications (8%). The detailed appearance of calcifications in thyroid nodules has not been well studied, especially for infracentimetric nodules, and further studies are needed to better define this US feature as an indicator of malignancy.
Comparison of histopathology and US-FNAB cytology of infracentimetric nodules showed that the diagnostic accuracy, sensitivity, and specificity of US-FNAB are high: 87, 92, and 83%, respectively. These results are not surprising, considering the continuing advances in the technology of high resolution US and increases in operator skill. Kim et al. [18] showed similar high diagnostic accuracy for US-FNAB of infracentimetric nodules. In contrast, Leenhardt et al. [19] concluded US-FNAB has limited diagnostic capability in small nodules, that the probability of obtaining adequate cytological material increases significantly with nodule size, and that US-FNAB is indicated primarily for centimetric or supracentimetric nodules, or for solid and hypoechoic nodules. In our study, when repeated FNAB were performed, only 5.7% of FNAB samples were inadequate for diagnostic cytology. Regardless of the nodule size, our results suggest that US-FNAB should be performed on nodules that show at least one of the US features that we found to be suggestive of malignancy: solid internal content, taller than wide shape, marked hypoechogenicity, or calcifications. The high sensitivity, specificity, and accuracy, of US examination demonstrated by our study confirm the usefulness of these US features as indications for FNAB of infracentimetric nodules.
The limitations of this study is that study populations are not complete consecutive screening patients but are consists of radiology department referred patients so this study does not represent the general population. Also several US features used as a risk factor of malignancy does still have appreciable overlap with benign, specifically, in this series we do not know how much selection biases were used for patients to get to surgical removal so a prospective series determining outcome of non-biopsied lesions would be necessary to determine the value of US signs in determining the need to perform FNAB.
The benefit of early detection of thyroid cancer when it is less than 1 cm has not been established but needs to be studied further since many papillary thyroid microcarcinomas are being detected and weather it is benign or malignant diagnosed is somewhat controversial. We recommend for infracentimetric nodules that has at least one of the US features that we found to be suggestive of malignancy should undergo US guided FNAB and should not be based on size.
